PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy

Nicholas Ieronimakis, Aislinn Hays, Amalthiya Prasad, Kajohnkiart Janebodin, Jeremy S. Duffield, Morayma Reyes Gil

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Fibrosis is a characteristic of Duchenne muscular dystrophy (DMD), yet the cellular and molecular mechanisms responsible for DMD fibrosis are poorly understood. Utilizing the Collagen1a1-GFP transgene to identify cells producing Collagen-I matrix in wild-type mice exposed to toxic injury or those mutated at the dystrophin gene locus (mdx) as a model of DMD, we studied mechanisms of skeletal muscle injury/repair and fibrosis. PDGFRα is restricted to Sca1+, CD45- mesenchymal progenitors. Fate-mapping experiments using inducible CreER/LoxP somatic recombination indicate that these progenitors expand in injury or DMD to become PDGFRα+, Col1a1-GFP+ matrix-forming fibroblasts, whereas muscle fibres do not become fibroblasts but are an important source of the PDGFRα ligand, PDGF-AA. While in toxin injury/repair of muscle PDGFRα, signalling is transiently up-regulated during the regenerative phase in the DMD model and in human DMD it is chronically overactivated. Conditional expression of the constitutively active PDGFRα D842V mutation in Collagen-I+ fibroblasts, during injury/repair, hindered the repair phase and instead promoted fibrosis. In DMD, treatment of mdx mice with crenolanib, a highly selective PDGFRα/β tyrosine kinase inhibitor, reduced fibrosis, improved muscle strength, and was associated with decreased activity of Src, a downstream effector of PDGFRα signalling. These observations are consistent with a model in which PDGFRα activation of mesenchymal progenitors normally regulates repair of the injured muscle, but in DMD persistent and excessive activation of this pathway directly drives fibrosis and hinders repair. The PDGFRα pathway is a potential new target for treatment of progressive DMD.

Original languageEnglish (US)
JournalJournal of Pathology
DOIs
StateAccepted/In press - 2016

Fingerprint

Duchenne Muscular Dystrophy
Collagen
Fibrosis
Wounds and Injuries
Fibroblasts
Muscles
Inbred mdx Mouse
Dystrophin
Poisons
Muscle Strength
Transgenes
Protein-Tyrosine Kinases
Genetic Recombination
Skeletal Muscle
Ligands
Mutation

Keywords

  • Collagen-producing cells
  • Duchenne muscular dystrophy
  • Fibrosis
  • PDGFRα signalling
  • Skeletal muscle

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy. / Ieronimakis, Nicholas; Hays, Aislinn; Prasad, Amalthiya; Janebodin, Kajohnkiart; Duffield, Jeremy S.; Reyes Gil, Morayma.

In: Journal of Pathology, 2016.

Research output: Contribution to journalArticle

Ieronimakis, Nicholas ; Hays, Aislinn ; Prasad, Amalthiya ; Janebodin, Kajohnkiart ; Duffield, Jeremy S. ; Reyes Gil, Morayma. / PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy. In: Journal of Pathology. 2016.
@article{e031aedc7036495d8a927a5b0fca6d4c,
title = "PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy",
abstract = "Fibrosis is a characteristic of Duchenne muscular dystrophy (DMD), yet the cellular and molecular mechanisms responsible for DMD fibrosis are poorly understood. Utilizing the Collagen1a1-GFP transgene to identify cells producing Collagen-I matrix in wild-type mice exposed to toxic injury or those mutated at the dystrophin gene locus (mdx) as a model of DMD, we studied mechanisms of skeletal muscle injury/repair and fibrosis. PDGFRα is restricted to Sca1+, CD45- mesenchymal progenitors. Fate-mapping experiments using inducible CreER/LoxP somatic recombination indicate that these progenitors expand in injury or DMD to become PDGFRα+, Col1a1-GFP+ matrix-forming fibroblasts, whereas muscle fibres do not become fibroblasts but are an important source of the PDGFRα ligand, PDGF-AA. While in toxin injury/repair of muscle PDGFRα, signalling is transiently up-regulated during the regenerative phase in the DMD model and in human DMD it is chronically overactivated. Conditional expression of the constitutively active PDGFRα D842V mutation in Collagen-I+ fibroblasts, during injury/repair, hindered the repair phase and instead promoted fibrosis. In DMD, treatment of mdx mice with crenolanib, a highly selective PDGFRα/β tyrosine kinase inhibitor, reduced fibrosis, improved muscle strength, and was associated with decreased activity of Src, a downstream effector of PDGFRα signalling. These observations are consistent with a model in which PDGFRα activation of mesenchymal progenitors normally regulates repair of the injured muscle, but in DMD persistent and excessive activation of this pathway directly drives fibrosis and hinders repair. The PDGFRα pathway is a potential new target for treatment of progressive DMD.",
keywords = "Collagen-producing cells, Duchenne muscular dystrophy, Fibrosis, PDGFRα signalling, Skeletal muscle",
author = "Nicholas Ieronimakis and Aislinn Hays and Amalthiya Prasad and Kajohnkiart Janebodin and Duffield, {Jeremy S.} and {Reyes Gil}, Morayma",
year = "2016",
doi = "10.1002/path.4801",
language = "English (US)",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy

AU - Ieronimakis, Nicholas

AU - Hays, Aislinn

AU - Prasad, Amalthiya

AU - Janebodin, Kajohnkiart

AU - Duffield, Jeremy S.

AU - Reyes Gil, Morayma

PY - 2016

Y1 - 2016

N2 - Fibrosis is a characteristic of Duchenne muscular dystrophy (DMD), yet the cellular and molecular mechanisms responsible for DMD fibrosis are poorly understood. Utilizing the Collagen1a1-GFP transgene to identify cells producing Collagen-I matrix in wild-type mice exposed to toxic injury or those mutated at the dystrophin gene locus (mdx) as a model of DMD, we studied mechanisms of skeletal muscle injury/repair and fibrosis. PDGFRα is restricted to Sca1+, CD45- mesenchymal progenitors. Fate-mapping experiments using inducible CreER/LoxP somatic recombination indicate that these progenitors expand in injury or DMD to become PDGFRα+, Col1a1-GFP+ matrix-forming fibroblasts, whereas muscle fibres do not become fibroblasts but are an important source of the PDGFRα ligand, PDGF-AA. While in toxin injury/repair of muscle PDGFRα, signalling is transiently up-regulated during the regenerative phase in the DMD model and in human DMD it is chronically overactivated. Conditional expression of the constitutively active PDGFRα D842V mutation in Collagen-I+ fibroblasts, during injury/repair, hindered the repair phase and instead promoted fibrosis. In DMD, treatment of mdx mice with crenolanib, a highly selective PDGFRα/β tyrosine kinase inhibitor, reduced fibrosis, improved muscle strength, and was associated with decreased activity of Src, a downstream effector of PDGFRα signalling. These observations are consistent with a model in which PDGFRα activation of mesenchymal progenitors normally regulates repair of the injured muscle, but in DMD persistent and excessive activation of this pathway directly drives fibrosis and hinders repair. The PDGFRα pathway is a potential new target for treatment of progressive DMD.

AB - Fibrosis is a characteristic of Duchenne muscular dystrophy (DMD), yet the cellular and molecular mechanisms responsible for DMD fibrosis are poorly understood. Utilizing the Collagen1a1-GFP transgene to identify cells producing Collagen-I matrix in wild-type mice exposed to toxic injury or those mutated at the dystrophin gene locus (mdx) as a model of DMD, we studied mechanisms of skeletal muscle injury/repair and fibrosis. PDGFRα is restricted to Sca1+, CD45- mesenchymal progenitors. Fate-mapping experiments using inducible CreER/LoxP somatic recombination indicate that these progenitors expand in injury or DMD to become PDGFRα+, Col1a1-GFP+ matrix-forming fibroblasts, whereas muscle fibres do not become fibroblasts but are an important source of the PDGFRα ligand, PDGF-AA. While in toxin injury/repair of muscle PDGFRα, signalling is transiently up-regulated during the regenerative phase in the DMD model and in human DMD it is chronically overactivated. Conditional expression of the constitutively active PDGFRα D842V mutation in Collagen-I+ fibroblasts, during injury/repair, hindered the repair phase and instead promoted fibrosis. In DMD, treatment of mdx mice with crenolanib, a highly selective PDGFRα/β tyrosine kinase inhibitor, reduced fibrosis, improved muscle strength, and was associated with decreased activity of Src, a downstream effector of PDGFRα signalling. These observations are consistent with a model in which PDGFRα activation of mesenchymal progenitors normally regulates repair of the injured muscle, but in DMD persistent and excessive activation of this pathway directly drives fibrosis and hinders repair. The PDGFRα pathway is a potential new target for treatment of progressive DMD.

KW - Collagen-producing cells

KW - Duchenne muscular dystrophy

KW - Fibrosis

KW - PDGFRα signalling

KW - Skeletal muscle

UR - http://www.scopus.com/inward/record.url?scp=84991826664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991826664&partnerID=8YFLogxK

U2 - 10.1002/path.4801

DO - 10.1002/path.4801

M3 - Article

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

ER -